In a delightful twist of science and snacking, researchers at the University of Pennsylvania’s School of Dental Medicine have developed a chewing gum made from lablab beans that significantly reduces the transmission of influenza and herpes viruses. According to the study published in Molecular Therapy, the gum neutralized herpes simplex viruses 1 and 2, as well as two strains of influenza, reducing viral loads by over 95%. Remarkably, the gum maintained its antiviral properties for up to 823 days at room temperature.
Lablab beans, also known as hyacinth beans, contain a natural antiviral protein called FRIL, which binds to viruses and prevents their spread. This innovative approach targets the mouth—the primary point of transmission for these viruses—offering a simple and effective method to curb infections. Given the declining flu vaccination rates and the absence of a herpes vaccine, this bean-based gum could be a game-changer in public health.
Professor Henry Daniell and his team are optimistic about the gum’s potential, especially in light of recent bird flu outbreaks. With its long shelf life and natural ingredients, this gum could soon become a staple in our fight against viral infections. Imagine medication coming soon to a candy counter near you. The audacity of hope!
